Roche NimbleGen, Inc Offers Comprehensive Epigenomic and Transcriptional Regulation Tools with HD2 (2.1 Million Probes) Arrays and Services

MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen has expanded its growing line of tools for analyzing the epigenome and genome-wide transcriptional regulation mechanisms by launching HD2 (2.1 million probes) arrays and services for chromatin immunoprecipitation (ChIP-chip). NimbleGen ChIP-chip HD2 arrays now provide more than a 5-fold increase in probe density per array, which allows for increasing the coverage of key biological features, such as promoters and CpG islands, and decreasing the number of arrays needed to perform whole-genome analysis at high resolution.
MORE ON THIS TOPIC